161 related articles for article (PubMed ID: 35830859)
1. IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage.
Lança T; Ungerbäck J; Da Silva C; Joeris T; Ahmadi F; Vandamme J; Svensson-Frej M; Mowat AM; Kotarsky K; Sigvardsson M; Agace WW
Immunity; 2022 Aug; 55(8):1431-1447.e11. PubMed ID: 35830859
[TBL] [Abstract][Full Text] [Related]
2. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
[TBL] [Abstract][Full Text] [Related]
3. Who on IRF are you? IRF8 deficiency redirects cDC1 lineage commitment.
Waller K; Scott CL
Trends Immunol; 2022 Sep; 43(9):687-689. PubMed ID: 35963772
[TBL] [Abstract][Full Text] [Related]
4. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
[TBL] [Abstract][Full Text] [Related]
5. Merocytic Dendritic Cells Compose a Conventional Dendritic Cell Subset with Low Metabolic Activity.
Audiger C; Fois A; Thomas AL; Janssen E; Pelletier M; Lesage S
J Immunol; 2020 Jul; 205(1):121-132. PubMed ID: 32461238
[TBL] [Abstract][Full Text] [Related]
6. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S
J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189
[TBL] [Abstract][Full Text] [Related]
7. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
[TBL] [Abstract][Full Text] [Related]
8.
Liu TT; Ou F; Belk JA; Bagadia P; Anderson DA; Durai V; Yao W; Satpathy AT; Murphy TL; Murphy KM
Genes Dev; 2023 Apr; 37(7-8):291-302. PubMed ID: 36990511
[TBL] [Abstract][Full Text] [Related]
9. Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage.
Bajana S; Thomas K; Georgescu C; Zhao Y; Wren JD; Kovats S; Sun XH
Front Immunol; 2020; 11():577718. PubMed ID: 33391258
[TBL] [Abstract][Full Text] [Related]
10. Single cell RNA-Seq reveals pre-cDCs fate determined by transcription factor combinatorial dose.
Ma W; Lee J; Backenroth D; Zhou YJ; Bush E; Sims P; Liu K; Shen Y
BMC Mol Cell Biol; 2019 Jun; 20(1):20. PubMed ID: 31253076
[TBL] [Abstract][Full Text] [Related]
11.
Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
[TBL] [Abstract][Full Text] [Related]
12. Single cell RNA sequencing reveals distinct clusters of Irf8-expressing pulmonary conventional dendritic cells.
Jirmo AC; Grychtol R; Gaedcke S; Liu B; DeStefano S; Happle C; Halle O; Monteiro JT; Habener A; Breiholz OD; DeLuca D; Hansen G
Front Immunol; 2023; 14():1127485. PubMed ID: 37251386
[TBL] [Abstract][Full Text] [Related]
13. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
[TBL] [Abstract][Full Text] [Related]
14. IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively.
Sichien D; Scott CL; Martens L; Vanderkerken M; Van Gassen S; Plantinga M; Joeris T; De Prijck S; Vanhoutte L; Vanheerswynghels M; Van Isterdael G; Toussaint W; Madeira FB; Vergote K; Agace WW; Clausen BE; Hammad H; Dalod M; Saeys Y; Lambrecht BN; Guilliams M
Immunity; 2016 Sep; 45(3):626-640. PubMed ID: 27637148
[TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.
Rosa FF; Pires CF; Kurochkin I; Halitzki E; Zahan T; Arh N; Zimmermannová O; Ferreira AG; Li H; Karlsson S; Scheding S; Pereira CF
Sci Immunol; 2022 Mar; 7(69):eabg5539. PubMed ID: 35245086
[TBL] [Abstract][Full Text] [Related]
16. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
Front Immunol; 2019; 10():173. PubMed ID: 30800127
[TBL] [Abstract][Full Text] [Related]
17. An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
Bagadia P; Huang X; Liu TT; Durai V; Grajales-Reyes GE; Nitschké M; Modrusan Z; Granja JM; Satpathy AT; Briseño CG; Gargaro M; Iwata A; Kim S; Chang HY; Shaw AS; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1174-1185. PubMed ID: 31406377
[TBL] [Abstract][Full Text] [Related]
18. Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans.
Cytlak U; Resteu A; Pagan S; Green K; Milne P; Maisuria S; McDonald D; Hulme G; Filby A; Carpenter B; Queen R; Hambleton S; Hague R; Lango Allen H; Thaventhiran JED; Doody G; Collin M; Bigley V
Immunity; 2020 Aug; 53(2):353-370.e8. PubMed ID: 32735845
[TBL] [Abstract][Full Text] [Related]
19. Type 1 conventional dendritic cell fate and function are controlled by DC-SCRIPT.
Zhang S; Coughlan HD; Ashayeripanah M; Seizova S; Kueh AJ; Brown DV; Cao W; Jacquelot N; D'Amico A; Lew AM; Zhan Y; Tonkin CJ; Villadangos JA; Smyth GK; Chopin M; Nutt SL
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33811060
[TBL] [Abstract][Full Text] [Related]
20. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells.
Sontag S; Förster M; Qin J; Wanek P; Mitzka S; Schüler HM; Koschmieder S; Rose-John S; Seré K; Zenke M
Stem Cells; 2017 Apr; 35(4):898-908. PubMed ID: 28090699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
